Non-Hodgkin Lymphoma Treatment World Markets to 2025

7/19, 1:05 PM (Source: GlobeNewswire)

Dublin, July 19, 2019 (GLOBE NEWSWIRE) -- The "Non-Hodgkin Lymphoma Treatment Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025" report has been added to ResearchAndMarkets.com's offering.

The report predicts the global non-hodgkin lymphoma treatment market to grow with a CAGR of 7.2% over the forecast period from 2019-2025.

The report on the global non-hodgkin lymphoma treatment market. provides qualitative and quantitative analysis for the period from 2017 to 2025. The study on non-hodgkin lymphoma treatment market. covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on non-hodgkin lymphoma treatment market. is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global non-hodgkin lymphoma treatment market. over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global non-hodgkin lymphoma treatment market. over the period of 2017 to 2025. Further, the Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • The rising prevalence of non-Hodgkin lymphoma disease
  • The increase in research and development of therapeutic drugs against the disease

2) Restraints

  • The high cost of the treatment

3) Opportunities

  • The improvement in non-Hodgkin lymphoma treatments is giving opportunity

What does this report deliver?

1. Comprehensive analysis of the global as well as regional markets of the non-hodgkin lymphoma treatment market.
2. Complete coverage of all the segments in the non-hodgkin lymphoma treatment market. to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global non-hodgkin lymphoma treatment market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Key Topics Covered

1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Non-Hodgkin Lymphoma Treatment Market Highlights
2.2. Non-Hodgkin Lymphoma Treatment Market Projection
2.3. Non-Hodgkin Lymphoma Treatment Market Regional Highlights

3. Global Non-Hodgkin Lymphoma Treatment Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Treatment Type
3.4.2. Growth Matrix Analysis by Cell Type
3.4.3. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Non-Hodgkin Lymphoma Treatment Market

4. Non-Hodgkin Lymphoma Treatment Market Macro Indicator Analysis

5. Global Non-Hodgkin Lymphoma Treatment Market by Treatment Type
5.1. Immunotherapy
5.2. Chemotherapy
5.3. Targeted Therapy
5.4. Radiation
5.5. Stem Cell Transplant

6. Global Non-Hodgkin Lymphoma Treatment Market by Cell Type
6.1. B-Cell
6.2. T-Cell

7. Global Non-Hodgkin Lymphoma Treatment Market by Region 2019-2025
7.1. North America
7.1.1. North America Non-Hodgkin Lymphoma Treatment Market by Treatment Type
7.1.2. North America Non-Hodgkin Lymphoma Treatment Market by Cell Type
7.1.3. North America Non-Hodgkin Lymphoma Treatment Market by Country
7.2. Europe
7.3. Asia-Pacific
7.4. RoW

8. Company Profiles and Competitive Landscape
8.1. Competitive Landscape in the Global Non-Hodgkin Lymphoma Treatment Market
8.2. Companies Profiled
8.2.1. AbbVie
8.2.2. Nordic Nanovector ASA
8.2.3. Pharmacyclics LLC
8.2.4. Bayer AG
8.2.5. Novartis International AG
8.2.6. Eli Lilly & Company
8.2.7. Amgen Inc.
8.2.8. F. Hoffmann-La Roche Ltd.
8.2.9. Other Companies

For more information about this report visit https://www.researchandmarkets.com/r/sy53hl

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Lymphoma Drugs 

Primary Logo

Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.